relative to the 340B discounted drug purchasing program.

HB 1755 requires New Hampshire hospitals and clinics participating in the federal 340B drug discount program to annually report detailed financial data to the state Department of Health and Human Services and the Attorney General. This includes costs of drugs purchased under the program, payments received, how savings are used for charity care or community health services, and patient demographics broken down by payer type (e.g., Medicaid, uninsured). The report must cover all 340B-covered entities with a New Hampshire service address, including offsite facilities. The state will compile and share aggregated data with the legislature to increase transparency around how program savings benefit patients.